《Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-FluorouracilLeucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer》.pdfVIP

Clin Oncol Cancer Res (2009) 6: 117-123 117 DOI 10.1007/s11805-009-0117-8 Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer Yuanjue Sun OBJECTIVE To estimate the short-time efficacy, side Hui Zhao effects, survival rate after the treatment of combining Yaowu Guo chemotherapy of oxaliplatin or 5-fluorouracil/leucovorin with hydroxycamptothecine (HCPT) for the patients with advanced Feng Lin colorectal cancer. Lina Tang METHODS From January 2002 to November 2005, 59 patients Yang Yao with advanced colorectal cancer confirmed by pathology were enrolled into this study in the department of medical oncology, in the Sixth People’s Hospital of Shanghai Jiaotong University, Shanghai. Patients’ characteristics in two groups were similarly confirmed by statistic. All 37 patients in OH group received Department of Medical Oncology, The Sixth oxaliplatin (130 mg/m2 d1) plus hydroxycamptothecine (6 mg/m2 d1-4), and all 22 patients in the HLF group received People’s Hospital of Shanghai Jiaotong Uni- 2 hydroxycampt